腹腔镜结直肠手术后安全早期出院的评估标准
这项前瞻性单中心队列研究纳入287例腹腔镜结直肠手术患者,评估C反应蛋白(CRP)联合4项临床标准排除吻合口漏的诊断性能,以支持术后第2或3天早期出院。5项标准全部满足者的吻合口漏风险显著低于未满足者(HR 0.15,95%CI 0.03-0.69;P=0.01),5项标准联合的阴性预测值为98.4%(95%CI 94.5%-99.8%),假阴性率13.3%(95%CI 0%-40.5%)。作者认为这5项标准有潜力实现安全早期出院。
要点
- 5项出院标准全部满足者吻合口漏风险显著低于未满足者(HR 0.15,95%CI 0.03-0.69;P=0.01)。
- 5项标准联合排除吻合口漏的阴性预测值为98.4%(95%CI 94.5%-99.8%),假阴性率13.3%(95%CI 0%-40.5%)。
- 128例满足全部标准者中76例(59.4%)在术后第3天前成功出院。
核心结论
- 这5项标准具有高阴性预测值和最低的假阴性率,表明其有潜力在腹腔镜结直肠手术后实现安全早期出院。
研究设计与样本
- 前瞻性单中心队列研究,2012年2月至2017年7月连续纳入所有接受腹腔镜结直肠手术的成年患者,共287例(中位[IQR]年龄58[20]岁;男性141例[49%],女性146例[51%]),术后随访30天,数据分析于2021年5月进行。
主要发现
- 死亡率为0%,共发生17例吻合口漏,其中2例发生于第1天并被排除。
- 128例满足全部标准,125例未满足(包括34例数据缺失);满足全部标准者中发生2例漏,未满足者中发生13例漏(HR 0.15,95%CI 0.03-0.69;P=0.01)。
- 128例满足全部标准者中76例(59.4%)在术后第3天前成功出院。
- 排除吻合口漏的阴性预测值:CRP单独为96.9%(95%CI 93.3%-98.8%),4项临床标准为98.4%(95%CI 95.3%-99.7%),5项标准联合为98.4%(95%CI 94.5%-99.8%)。
- 假阴性率:CRP单独为40%(95%CI 16.3%-67.7%),其他4项标准为20%(95%CI 4.3%-48.1%),5项标准联合为13.3%(95%CI 0%-40.5%)。
关键数值与推荐
- 5项出院标准为:出院当日CRP水平低于150 mg/dL、肠功能恢复、耐受饮食、视觉模拟量表疼痛评分低于5分(满分10分)、整个住院期间无发热。
- 满足标准定义为在术后第3天(或第2天出院的患者在术后第2天)满足上述5项标准。
- 成功出院定义为患者在术后第2或3天出院且无任何并发症或再入院。
临床怎么用
- 作者认为这5项标准有潜力在腹腔镜结直肠手术后实现安全早期出院。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Early discharge after colorectal surgery has been advocated. However, there is little research evaluating clinical and/or laboratory criteria to determine who can be safely discharged early. OBJECTIVE: To evaluate the diagnostic performance of a C-reactive protein (CRP) level combined with 4 clinical criteria in ruling out an anastomotic leak and therefore allowing an early discharge on postoperative day 2 or 3. DESIGN, SETTING, AND PARTICIPANTS: This prospective, single-center cohort study was performed between February 2012 and July 2017. All consecutive adult patients undergoing laparoscopic colorectal surgery were included. All patients were followed up for 30 days postoperatively. Data analysis was performed in May 2021. EXPOSURES: Whether the 5 discharge criteria were fulfilled on postoperative day 3 (or day 2 for patients discharged on day 2). Fulfillment was defined as a CRP level less than 150 mg/dL on the day of discharge, a return of bowel function, tolerance of a diet, pain less than 5 of 10 on a visual analog scale, and being afebrile during the entire stay. MAIN OUTCOMES AND MEASURES: The primary outcome measurement was the diagnostic performance of the 5 discharge criteria in anticipating anastomotic leak development. The diagnostic performance of CRP level alone and 4 clinical criteria alone was also evaluated. Secondary measures were anastomotic leaks and mortality rates up to postoperative day 30. A discharge was successful if the patient left the hospital on postoperative day 2 or 3 without any complications or readmissions. RESULTS: A total of 287 patients were included (median [IQR] age, 58 [20] years; 141 men [49%] and 146 women [51%]). Mortality was 0%. There were 17 anastomotic leaks, of which 2 were on day 1 and were excluded. A total of 128 patients fulfilled all criteria, and 125 did not, including 34 for whom data were missing. Two leaks occurred in patients who had fulfilled all criteria vs 13 leaks in patients who did not (hazard ratio, 0.15 [95% CI, 0.03-0.69]; P = .01). Seventy-six of 128 patients (59.4%) were discharged successfully by postoperative day 3. The negative predictive value in ruling out an anastomotic leak was at least 96.9% for CRP alone (96.9% [95% CI, 93.3%-98.8%]), the 4 clinical criteria (98.4% [95% CI, 95.3%-99.7%]), and all 5 criteria combined (98.4% [95% CI, 94.5%-99.8%]). False-negative rates were 40% (95% CI, 16.3%-67.7%) for CRP level alone, 20% (95% CI, 4.3%-48.1%) for the other 4 criteria, and 13.3% (95% CI, 0%-40.5%) for all 5 criteria. CONCLUSIONS AND RELEVANCE: These 5 criteria have a high negative predictive value and the lowest false-negative rate, indicating they have the potential to allow for safe early discharge after laparoscopic colorectal surgery.
引用
- Tavernier C, Flaris AN, Passot G, et al. Assessing Criteria for a Safe Early Discharge After Laparoscopic Colorectal Surgery. JAMA Surg. 2022. PMID: 34730770. doi:10.1001/jamasurg.2021.5551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。